PFIZER INC Dividends, Preferred Stock
PFIZER INC (PFE) reported Dividends, Preferred Stock of $1.00 million for the 3-month period ending 2014-06-29, per its 10-Q filed 2014-08-07.
Discontinued › Shareholders' Equity › Dividends, Preferred Stock
us-gaap:DividendsPreferredStock · last filed 2014-08-07
- PFIZER INC dividends, preferred stock for the quarter ending 2014-06-29 was $1.00M.
- PFIZER INC dividends, preferred stock for the quarter ending 2014-03-30 was $0.00.
- PFIZER INC dividends, preferred stock for the quarter ending 2013-12-31 was $1.00M, a 0.00% change year-over-year.
- PFIZER INC dividends, preferred stock for the quarter ending 2013-09-29 was $0.00, a 100.00% decline year-over-year.
- PFIZER INC dividends, preferred stock for fiscal 2013 was $2.00M, a 0.00% change from fiscal 2012.
- PFIZER INC dividends, preferred stock for fiscal 2012 was $2.00M, a 0.00% change from fiscal 2011.
- PFIZER INC dividends, preferred stock for fiscal 2011 was $2.00M, a 0.00% change from fiscal 2010.
- PFIZER INC dividends, preferred stock for fiscal 2010 was $2.00M, a 0.00% change from fiscal 2009.
| Period end | Dividends, Preferred Stock 3 month | Dividends, Preferred Stock 6 month | Dividends, Preferred Stock 9 month | Dividends, Preferred Stock 12 month |
|---|---|---|---|---|
| 2014-06-29 | $1.00M 10-Q · filed 2014-08-07 | $1.00M 10-Q · filed 2014-08-07 | $2.00M derived: sum of 3 quarters · filed 2014-08-07 | $2.00M derived: sum of 4 quarters · filed 2014-08-07 |
| 2014-03-30 | $0.00 10-Q · filed 2014-05-08 | $1.00M derived: sum of 2 quarters · filed 2014-05-08 | $1.00M derived: sum of 3 quarters · filed 2014-05-08 | $1.00M derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $1.00M derived: sum of 2 quarters · filed 2014-02-28 | $1.00M derived: sum of 3 quarters · filed 2014-08-07 | $2.00M 10-K · filed 2014-02-28 |
| 2013-09-29 | $0.00 10-Q · filed 2013-11-08 | $0.00 derived: sum of 2 quarters · filed 2014-08-07 | $1.00M 10-Q · filed 2013-11-08 | $1.00M derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-06-30 | $0.00 10-Q · filed 2014-08-07 | $1.00M 10-Q · filed 2014-08-07 | $1.00M derived: sum of 3 quarters · filed 2014-08-07 | $2.00M derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-08 | $1.00M derived: sum of 2 quarters · filed 2014-05-08 | $2.00M derived: sum of 3 quarters · filed 2014-05-08 | $2.00M derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $2.00M derived: sum of 2 quarters · filed 2014-02-28 | $2.00M derived: sum of 3 quarters · filed 2014-02-28 | $2.00M 10-K · filed 2014-02-28 |
| 2012-09-30 | $1.00M 10-Q · filed 2013-11-08 | $1.00M derived: sum of 2 quarters · filed 2013-11-08 | $1.00M 10-Q · filed 2013-11-08 | $2.00M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-07-01 | $0.00 10-Q · filed 2013-08-09 | $1.00M 10-Q · filed 2013-08-09 | $1.00M derived: sum of 3 quarters · filed 2014-02-28 | $1.00M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-04-01 | $0.00 10-Q · filed 2013-05-10 | $1.00M derived: sum of 2 quarters · filed 2014-02-28 | $1.00M derived: sum of 3 quarters · filed 2014-02-28 | |
| 2011-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $1.00M derived: sum of 2 quarters · filed 2014-02-28 | $2.00M 10-K · filed 2014-02-28 | |
| 2011-10-02 | $0.00 10-Q · filed 2012-11-09 | $1.00M 10-Q · filed 2012-11-09 | ||
| 2011-07-03 | $1.00M 10-Q · filed 2012-08-09 | |||
| 2010-12-31 | $2.00M 10-K · filed 2013-02-28 | |||
| 2010-10-03 | $1.00M 10-Q · filed 2011-11-10 | $2.00M derived: sum of 2 quarters · filed 2011-11-10 | $2.00M 10-Q · filed 2011-11-10 | |
| 2010-07-04 | $1.00M 10-Q · filed 2011-08-11 | $1.00M 10-Q · filed 2011-08-11 | ||
| 2010-04-04 | $1.00M 10-Q · filed 2011-05-12 | |||
| 2009-12-31 | $2.00M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |